NCT04437940

Brief Summary

Aim of the study is to investigate whether the Covid-19 is found in the vaginal swab samples of female patients diagnosed with covid-19, to evaluate the presence of Covid-19 and the risk of transmission of Covid-19 by intercourse or vaginal delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 17, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 18, 2020

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

January 12, 2021

Status Verified

January 1, 2021

Enrollment Period

25 days

First QC Date

June 17, 2020

Last Update Submit

January 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Vaginal fluid Covid-19 PCR test result

    Vaginal fluid Covid-19 test positivity rate for patients whose nasofarengeal test is positive

    1 month

Secondary Outcomes (1)

  • becoming negative from positive

    2 month

Study Arms (1)

Covid-19 positive women

Women with nasofarangeal Covid-19 PCR test is positive

Diagnostic Test: Vaginal fluid Covid-19 PCR test

Interventions

Vaginal fluid samples are tested for Covid-19

Covid-19 positive women

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen who are older than 18 years old Women who had sexual intercourse before
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Women who are older than18 years old, who are considered to be covid-19 clinically and radiologically positive or nasofarengeal Covid-19 PCR test is positive will be included. Patients previously treated for covid-19 will be excluded from the study.

You may qualify if:

  • Women who are positive nasofarengeal Covid-19 PCR test result
  • Women who are 18 years or older
  • Women who had sexual intercourse before

You may not qualify if:

  • who had medical treatment for Covid-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acibadem Maslak Hospital

Istanbul, 34457, Turkey (Türkiye)

Location

Related Publications (2)

  • Cui P, Chen Z, Wang T, Dai J, Zhang J, Ding T, Jiang J, Liu J, Zhang C, Shan W, Wang S, Rong Y, Chang J, Miao X, Ma X, Wang S. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract. Am J Obstet Gynecol. 2020 Jul;223(1):131-134. doi: 10.1016/j.ajog.2020.04.038. Epub 2020 May 4. No abstract available.

    PMID: 32376320BACKGROUND
  • Qiu L, Liu X, Xiao M, Xie J, Cao W, Liu Z, Morse A, Xie Y, Li T, Zhu L. SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection. Clin Infect Dis. 2020 Jul 28;71(15):813-817. doi: 10.1093/cid/ciaa375.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Vaginal fluid

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,Assistant Professor

Study Record Dates

First Submitted

June 17, 2020

First Posted

June 18, 2020

Study Start

June 15, 2020

Primary Completion

July 10, 2020

Study Completion

November 30, 2020

Last Updated

January 12, 2021

Record last verified: 2021-01

Locations